This inventor holds 1 USPTO granted patent. Top assignee: The University of Hong Kong. Active years: 2011.
Company Filing History:
Years Active: 2011
Title: Innovator in Drug Delivery: Ming Cheuk Chan
Introduction: Ming Cheuk Chan, an accomplished inventor based in Hong Kong, has made significant strides in the field of drug delivery systems. With a focus on creating biocompatible materials, Chan has developed innovative methods that enhance the efficacy of drug delivery while ensuring safety and stability.
Latest Patents: Chan holds a notable patent for "Collagen-based microspheres and methods of preparation and uses thereof." This invention revolves around the manufacturing of extracellular matrix microparticles that incorporate bioactive molecules for drug delivery. The patented method utilizes either a modified emulsification technique or a water-in-oil-phase-separation method, leading to photochemically crosslinked microspheres that optimize the release of bioactive molecules. This innovation is significant as it employs mild fabrication conditions, avoids toxic chemical crosslinking reagents, and eliminates the use of organic solvents, all of which could compromise biocompatibility or drug activity.
Career Highlights: Ming Cheuk Chan is affiliated with The University of Hong Kong, where he contributes to cutting-edge research in drug delivery and biomaterials. His work emphasizes the creation of highly biocompatible microspheres that maintain controlled size and release properties, making them invaluable in both drug delivery applications and cell culture environments.
Collaborations: Throughout his career, Chan has collaborated with esteemed colleagues such as Barbara Pui Chan and Kwok Fai So. These partnerships enhance the research outcomes and foster innovation in their shared field of study.
Conclusion: Ming Cheuk Chan stands as a prominent figure in the realm of biomedical engineering, particularly in drug delivery systems. His patent on collagen-based microspheres not only showcases his innovative capabilities but also reflects his commitment to advancing medical technologies that prioritize patient safety and treatment efficacy. As he continues to collaborate and innovate at The University of Hong Kong, the potential for future breakthroughs in drug delivery is promising.